Abstracts Archive - Page 421 of 1683 - ATC Abstracts

2020 American Transplant Congress
The Application of Electron Microscope Examination in Evaluation of Donor Liver Quality in Liver Transplantation
M. Chen¹, X. Lin², Z. Chen¹, M. Han¹, W. Ju¹, X. He¹
¹Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Division of General Surgery, The East Hospital of the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Liver transplantation (LT) is considered as the only curable treatment for patients with end stage liver diseases. Post-operative complications include early allograft dysfunction (EAD),…
2020 American Transplant Congress
DCD vs DBD Liver Transplantation: Equivalent Charges and Similar Survival- An Effective Expansion of the Donor Pool
N. Singh, K. Helfrich, M. Alebrahim, C. Akateh, K. Mumtaz, A. Logan, A. Schenk, S. Black, E. Elkhammas, K. Washburn, A. El-Hinnawi
Ohio State University, Columbus, OH
*Purpose: The shortage of allografts available for liver transplantation (LT) has prompted the need for expansion of donor pool to include donation after circulatory death…
2020 American Transplant Congress
Conversion to Belatacept (BLT)- from Calcineurin Inhibitor (CNI)-Based Immunosuppression During the First Year Post-Transplant (<1yr Tx) Increases Risk for CMV Infection Through Inhibition of Anti-CMV Humoral Immunity
B. Shin, N. Ammerman, S. Sethi, A. Vo, S. C. Jordan, M. Toyoda
Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: We have shown a higer CMV infection rate in kidney Tx patients (KTx Pts) who were converted to BLT 1yr post-Tx. Viral infections are…
2020 American Transplant Congress
Lose Weight to Donate Program: Preliminary Results of a Program Intended to Optimize Obese Living Donor Liver Candidates
J. Rose¹, T. Seay², A. Pesch³, P. Vargas⁴, S. Pelletier⁴, J. Oberholzer⁴, C. Argo⁵, N. Goldaracena⁴
¹School of Medicine, University of Virginia Health System, Charlottesville, VA, ²Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ³Radiology Department, University of Virginia Health System, Charlottesville, VA, ⁴Department of Surgery, Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ⁵Department of Medicine-Gastroenterology, University of Virginia Health System, Charlottesville, VA
*Purpose: Living donation (LD) can alleviate organ shortage, but is limited by obesity compromising organ quality and donor safety. This study intends to assess the…
2020 American Transplant Congress
Steatosis Quantification by MRI PDFF Effectively Identifies Liver Allografts at Low Risk for Recipient Complicationsin Living Donor Liver Transplantation
A. Duarte-Rojo, D. R. Jorgensen, Q. Qi, K. Chupetlovska, A. A. Borhani, A. Furlan, M. Molinari, S. Ganesh, A. Humar
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Novel methods to assess steatosis, such as proton density fat fraction (PDFF) from MRI provide an accurate and continuous quantification of mild steatosis. We…
2020 American Transplant Congress
Living versus Deceased Donor Liver Transplantation in Cholestatic Liver Disease: An Analysis of the OPTN Database
I. A. Ziogas¹, S. P. Alexopoulos¹, L. K. Matsuoka¹, S. K. Geevarghese¹, L. D. Gorden¹, S. J. Karp¹, J. D. Perkins², M. I. Montenovo¹
¹Vanderbilt University Medical Center, Nashville, TN, ²University of Washington, Seattle, WA
*Purpose: The current MELD allocation system does not accurately reflect the urgency of liver transplantation (LT) in cholestatic liver disease (CLD) patients. Therefore, more CLD…
2020 American Transplant Congress
Unresolved Disparities: Sex, Racial, Ethnic, and Insurance Differences in Performance Status at Listing for Liver Transplant
R. Rosenblatt, B. Fortune, A. Jesudian, C. Lucero, R. S. Brown, B. Samstein, J. Emond, E. Verna, K. Halazun
Center for Liver Disease and Transplantation, New York, NY
*Purpose: Cirrhosis is a chronic disease characterized by progressive worsening in physical functioning. We hypothesized that poor performance status at time of listing was an…
2020 American Transplant Congress
Predicting the Safe Use of Deceased after Circulatory Death Liver Allografts in Primary Sclerosing Cholangitis
V. Fleetwood, A. Gracon, D. Aufhauser, C. Papageorge, K. Janek, G. Leverson, D. Foley, J. Mezrich, A. D'Alessandro, L. Fernandez, D. Al-Adra
Department of Transplantation, University of Wisconsin, Madison, WI
*Purpose: The use of deceased after circulatory donation (DCD) liver allografts in patients with primary sclerosing cholangitis (PSC) is controversial given the already-increased risk of…
2020 American Transplant Congress
Understanding Attitudes and Perceptions about Liver Disease and Living-Donor Liver Transplant- Results of a National Survey
C. Zell¹, C. Caruso¹, T. Kirby², S. Piccirilli³, S. Ganesh⁴, J. Whyte⁵, A. Humar³
¹Clinical Marketing, UPMC, Pittsburgh, PA, ²Marketing Intelligence, UPMC, Pittsburgh, PA, ³Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, ⁴Clinical Marketing, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, ⁵WebMD, New York, NY
*Purpose: There are more than 14,000 people on the national waiting list for a liver transplant. Approximately 25% will die before receiving a life-saving transplant…
2020 American Transplant Congress
Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation
E. Palte¹, J. Duong², H. Remotti³, J. Burt³, A. Griesemer⁴, B. Samstein⁵, D. Marratta⁶, A. N. Fox⁷
¹Columbia University Vagelos College of Physicians and Surgeons, New York, NY, ²Columbia University Mailman School of Public Health, New York, NY, ³Department of Pathology and Cell Biology, Columbia University, New York, NY, ⁴Department of Surgery, Columbia University, New York, NY, ⁵Department of Surgery, Weill Cornell Medicine, New York, NY, ⁶Department of Medicine, Columbia University, New York, NY, ⁷Department of Medicine, Division of Digestive and Liver Diseases, Columbia University, New York, NY
*Purpose: Living donor liver transplantation (LDLT) increases the donor pool and affords a life-saving cure to recipients who do not have MELD-based access to allografts.…